Showing results (71-80 of 396) with videos related to
Sort By:
Pageof 40
Endocrine Reviews|August 6, 2004
Oxidative stress in the pathogenesis of diabetic neuropathyAndrea M Vincent, James W Russell, Phillip Low, et al.Drug Discovery Today|January 15, 2008
Strategic approaches to developing drug treatments for ALSAndrea M Vincent, Stacey A Sakowski, Adam Schuyler, et al.Annals of Neurology|September 10, 2011
Stem cell technology for neurodegenerative diseasesJ Simon Lunn, Stacey A Sakowski, Junguk Hur, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 29, 2005
Short-term hyperglycemia produces oxidative damage and apoptosis in neuronsAndrea M Vincent, Lisa L McLean, Carey Backus, et al.Neurobiology of Disease|June 15, 2004
IGF-I prevents glutamate-induced motor neuron programmed cell deathAndrea M Vincent, Bret C Mobley, Andrew Hiller, et al.The Laryngoscope|January 14, 2012
Potential for promoting recurrent laryngeal nerve regeneration by remote delivery of viral gene therapyAdam D Rubin, Norman D Hogikyan, Alex Oh, et al.Current Drug Targets|January 29, 2008
The antioxidant response as a drug target in diabetic neuropathyAndrea M Vincent, James L Edwards, Mahdieh Sadidi, et al.Growth Factors (Chur, Switzerland)|March 19, 2009
Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor deliveryJ Simon Lunn, Michael P Hefferan, Martin Marsala, et al.Current Treatment Options in Neurology|December 22, 2004
Polyneuropathy with Impaired Glucose Tolerance: Implications for Diagnosis and TherapyJ Robinson Singleton, A Gordon Smith, James Russell, et al.Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|July 23, 2005
Identification of candidate drugs for the treatment of ALSAndrea M Vincent, Carey Backus, Alexander A Taubman, et al.Pageof 40